Neogen Corporation Stock Upgraded (NEOG)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

NEW YORK ( TheStreet) -- Neogen Corporation (Nasdaq: NEOG) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The revenue growth came in higher than the industry average of 3.1%. Since the same quarter one year prior, revenues rose by 21.4%. This growth in revenue does not appear to have trickled down to the company's bottom line, displaying stagnant earnings per share.
  • NEOG has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 4.76, which clearly demonstrates the ability to cover short-term cash needs.
  • NEOGEN CORP reported flat earnings per share in the most recent quarter. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, NEOGEN CORP increased its bottom line by earning $0.75 versus $0.63 in the prior year. This year, the market expects an improvement in earnings ($0.77 versus $0.75).
  • The gross profit margin for NEOGEN CORP is rather high; currently it is at 53.51%. Regardless of NEOG's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 10.60% trails the industry average.
  • The change in net income from the same quarter one year ago has significantly exceeded that of the Health Care Equipment & Supplies industry average, but is less than that of the S&P 500. The net income has decreased by 1.1% when compared to the same quarter one year ago, dropping from $6.65 million to $6.58 million.

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. Neogen has a market cap of $1.52 billion and is part of the health care sector and drugs industry. Shares are down 7.9% year to date as of the close of trading on Wednesday.

You can view the full Neogen Ratings Report or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

The January Effect Could Push Up Some Stock Prices

The January Effect Could Push Up Some Stock Prices

Testing the Waters on Neogen? Don't Go There!

Testing the Waters on Neogen? Don't Go There!

Dec. 21 Premarket Briefing: 10 Things You Should Know

Dec. 21 Premarket Briefing: 10 Things You Should Know

Take Profits In Neogen Ahead of Second-Quarter Earnings

Take Profits In Neogen Ahead of Second-Quarter Earnings

Insider Trading Alert - FNB, NEOG And CHSP Traded By Insiders

Insider Trading Alert - FNB, NEOG And CHSP Traded By Insiders